Page last updated: 2024-09-05

erlotinib hydrochloride and Koch's Disease

erlotinib hydrochloride has been researched along with Koch's Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dahal, A; El-Sadek, M; Emam, AM; Enriz, RD; Ibrahim, SM; Jois, SD; Kothayer, H; Singh, SS; Tosso, RD	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Koch's Disease

Article	Year
Quinazoline-tethered hydrazone: A versatile scaffold toward dual anti-TB and EGFR inhibition activities in NSCLC. Archiv der Pharmazie, 2021, Volume: 354, Issue:12 Topics: A549 Cells; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fibroblasts; Humans; Hydrazones; Lung Neoplasms; Models, Molecular; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship; Tuberculosis	2021

Article

Year

Quinazoline-tethered hydrazone: A versatile scaffold toward dual anti-TB and EGFR inhibition activities in NSCLC.

Archiv der Pharmazie, 2021, Volume: 354, Issue:12

Topics: A549 Cells; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fibroblasts; Humans; Hydrazones; Lung Neoplasms; Models, Molecular; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship; Tuberculosis

2021